Menstrual endocrinology and pathology: Caffeine, physiology, and PMS

Caffeine and Activation Theory: Effects on Health and Behavior

Volumn , Issue , 2006, Pages 181-197

  Vo, Hoa T ^a   Smith, Barry D ^a   Elmi, Solmaz ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349210885     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (85)

1. American College of Obstetricians and Gynecologists (2000) Clinical management guidelines for obstetrician-gynecologists. Practice bulletin number 15: Premenstrual syndrome. Obstetrics & Gynecology, 95, 1-9.
2. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, 4th ed. text rev. Washington, D.C.: American Psychiatric Association.
3. Anderson, S. E., & Must, A. (2005). Interpreting the continued decline in the average age at menarche: results from two nationally representative surveys of U.S. girls studied 10 years apart. Journal of Pediatrics, 147, 753-760.
4. Apter, D., Raisanen, I., Ylostalo, P., & Vihko, R. (1987). Follicular growth in relation to serum hormonal patterns in adolescence compared with adult menstrual cycles. Fertility & Sterility, 47, 82-88.
5. Backstrom, T., & Carstensen, H. (1974). Estrogen and progesterone in plasma in relation to premenstrual tension. Journal of Steroid Biochemistry, 5, 257-260.
6. Backstrom, T., & Mattson, B. (1975). Correlation of symptoms in premenstrual tension to estrogen and progesterone concentrations in blood plasma. Neuropsychobiology, 1, 80-86.
7. Balogh, A., Irmisch, E., Klinger, G., Splinter, F. K., & Hoffmann, A. (1987). Elimination of caffeine and metamizol in the menstrual cycle of the fertile female. Zentralblatt fur Gynakologie, 109, 1135-1142.
8. Beem, A. L., Geus, E. J., Hottenga, J. J., Sullivan, P. F., Wilemsen, G., Slagboom, P. E., & Boomsma, D. I. (2005). Combined linkage and association analyses of the 124-bp allele of marker D2S2944 with anxiety, depression, neuroticism and major depression. Behavior Genetics, 24, 1-10.
9. Berlin, R. E, Jamuna, D. R., Schmidt, P. J., Adams, L. F., & Rubinow, D. R. (2001). Effects of the menstrual cycle on measures of personality in women with premenstrual syndrome: A preliminary study. Journal of Clinical Psychiatry, 62, 337-342.
10. Caan, B., Duncan, D., Hiatt, R., Lewis, J., Chapman, J., & Armstrong, M. A. (1993). Association between alcoholic and caffeinated beverages and premenstrual syndrome. Journal of Reproductive Medicine, 38, 630-636.
11. Chrisler, J. C., & Levy, K. B. (1990). The media construct a menstrual monster: A content analysis of PMS articles in the popular press. Women and Health, 16, 89-104.
12. Condon, J. T. (1993). The premenstrual syndrome: A twin study. British Journal of Psychiatry, 162, 481-486.
13. Coppen, A., & Kessel, N. (1963). Menstruation and personality, British Journal of Psychiatry, 109, 711-721.
14. Coutts, L. B., & Berg, D. H. (1993). The portrayal of the menstruating women in menstrual product advertisements. Health Care for Women International, 14, 179-191.
15. Dalton, K. (1979). The premenstrual syndrome and progesterone therapy. London: Heinemann Medical Books.
16. Dickerson, L. M., Mazyck, P. J., & Hunter, M. H. (2003). Premenstrual syndrome. American Family Physician, 67, 1743-1752.
17. Endicott, J. (2000). History, evolution, and diagnosis of premenstrual dysphoric disorder. Journal of Clinical Psychiatry, 61 (suppl 12), 5-8.
18. Endicott, J., Schacht, S., & Halbreich, U., & Nee, J. (1981). Premenstrual changes and affective disorders. Psychosomatic Medicine, 43, 519-529.
19. Fenster, L., Quale, C., Walker, K., Windham, G. C., Elkin, E. P., Benowitz, N., & Swan, S. H. (1999). Caffeine consumption and menstrual function. American Journal of Epidemiology, 149, 550-557.
20. FitzGerald, M., Malone, K. M., Li, S., Harrison, W. M., McBride, P. A., Endicott, J., Cooper, T., & Mann, J. J. (1997). Blunted serotonin response to femfluramine challenge in premenstrual dysphoric disorder. American Journal of Psychiatry, 154, 556-558.
21. Fraser, I. S., Michie, E. A., Wide, L., & Baird, D. T. (1973). Pituitary gonadotropin and ovarian function in adolescent dysfunctional uterine bleeding. Journal of Clinical Endocrinology & Metabolism, 37, 407-414.
22. Gallant, S., Hamilton, J., Popiel, D., Morokoff, P., & Chakraborty, P. K. (1991). Daily moods and symptoms: Effects of awareness of study focus, gender, menstrual cycle phase and day of week, Health Psychology, 10, 180-189.
23. Gotthell, M., Steinberg, R., & Granger, L. (1999). An exploration of clinicians' diagnostic approaches to premenstrual symptomatology. Canadian Journal of Behavior Science, 31, 254-262.
24. Halbreich, W., & Endicott, J. (1985). Relationship of dysphoric premenstrual changes to depressive disorders. Acta Psychiatr. Scand., 71, 331-338.
25. Halbreich, U., Endicott, J., & Lesser, J. (1985). The clinical diagnosis and classification of premenstrual changes. Canadian Journal of Psychiatry, 30, 489-497.
26. Hart, W., Coleman, G., & Russell, J. (1987). Assessment of premenstrual symptomatology: A re-evaluation of the predictive validity of self report. Journal of Psychosomatic Research, 31, 183-190.
27. Haskett, R. F., Steiner, M., & Carroll, B. J. (1984). A psychoendocrine study of premenstrual tension syndrome. A model for endogenous depression? Journal of Affective Disorders, 6, 191-199.
28. Hettema, J. M., Prescott, C. A., & Kendler, K. S. (2004). Generic and environmental sources of covariation between generalized anxiety disorder and neuroticism. American Journal of Psychiatry, 161, 1581-1587.
29. Institute of Medicine. (2001). Caffeine for the sustainment of mental task performance: Formulations for military operations. Washington, D.C.: National Academy Press.
30. James, J. E. (1997). Understanding caffeine: A biobehavioral analysis. Thousand Oaks, CA: Sage Publications.
31. Kaminori, G. H., Joubert, A., Otterstetter, R., Santaromana, M., & Eddington, N. D. (1999). The effect of the menstrual cycle on the pharmacokinetics of caffeine in normal, health eumenorrheic females. European Journal of Clinical Pharmacology, 55, 213-222.
32. Keller, M. C., Coventry, W. L., Heath, A. C., & Martin, N. G. (2005). Widespread evidence for nonadditive genetic variation in Cloniger's and Eysenck's personality dimensions using a twin plus sibling design. Behavior Genetics, 35, 707-721.
33. Khan-Sabir, N., & Carr, B. R. (2005, March 1). The normal menstrual cycle and the control of ovulation. www.endotext.org
34. Female, Reproductive Endocrinology Section, R. Rebar (Ed.) Retrieved, February 17, 2006, from www.endotext.org/female/female3/femaleframe3.htm.
35. Kim, D. R., Gyulai, L., Freeman, E. W., Morrison, M. F., Baldassano, C., & Dube, B. (2004). Premenstrual dysporic disorder and psychiatric comorbidity. Archives of Women in Mental Health, 7, 37-17.
36. Kornstein, S. G., Harvey, A. T., Rush, A. J., Wisniewski, S. R., Trivedi, M. H., Svikis, D. S., McKensie, N. D., Bryan, C., & Harley, R. (2005). Self-reported premenstrual exacerbation of depressive symptoms in patients seeking treatment for major depression. Psychological Medicine, 35, 683-692.
37. Lane, J. D., Steege, J. F., Rupp, S. L., & Kuhn, C. M. (1992). Menstrual cycle effects on caffeine elimination in the human female. European Journal of Clinical Pharmacology, 43, 543-546.
38. Li, J., & Thompson, D. S. (2001). Treating premenstrual dysphoric disorder using serotonin agents. Journal of Women's Health & Gender-Based Medicine, 10, 745-750.
39. Lucero, J., Harlow, B. L., Barbieri, R. L., Sluss, P., & Cramer, D. W. (2001). Early follicular phase hormone levels in relation to patterns of alcohol, tobacco, and coffee use. Fertility & Sterility, 76, 723-729.
40. Lustyk, K. B., Widman, L., Paschane, A. E., & Olson, K. C. (2004). Physical activity and quality of life: Assessing the influence of activity frequency, intensity, volume, and motives. Behavior Medicine, 30, 124-131.
41. Marks, J. L., Hair, C. S., Klock, S. C., Ginsburg, B. E., & Pomerleau, C. S. (1994). Effects of menstrual phase on intake of nicotine, caffeine, and alcohol and nonprescribed drugs in women with late luteal phase dysphoric disorder. Journal of Substance Abuse, 6(2), 235-243.
42. McLean, C., & Graham, T. E. (2002). Effects of exercise and thermal stress on caffeine pharmacokinetics in men and eumenorrheic women. Journal of Applied Physiology, 93(4), 1471-1478.
43. Merck Source. 2004. Harvard Health Website www.mercksource.com/pp/us/cns/cns_home.jsp.
44. Meyer, U. A., & Zanger, U.M. (1997). Molecular mechanisms of genetic polymorphisms of drug metabolism. Annual Review of Pharmacology and Toxicology, 37, 269-296.
45. Miller, L. (2002). Premenstrual dysphoric disorder. Psychiatric Times, June 1, pg. 54. Available online at www.web4.infotrac.galegroup.com.
46. Munday, M. R. (1997). A comprehensive evaluation of premenstrual syndrome. American Journal of Natural Medicine, 4, 6-20.
47. National Institute on Aging (n.d.) Age page. Retrieved February 17, 2006, from www.niapublications.org/agepages/menopause.asp.
48. National Women's Health Information Center. (2004). Frequently asked questions about menstruation and the menstrual cycle. Available at www.4woman.gov.
49. NIMH premenstrual syndrome workshop guidelines. (1983). National Institute of Mental Health, (not published), Rockville, MD.
50. Niswender, G. D., & Nett, T. M. (1994). The corpus luteum and its control in infraprimate species. In E. Knobil & J. D. Neill, (Eds.), The physiology of reproduction, 2nd ed., vol. 1 (p. 781). New York: Raven Press.
51. Paige, K. (1971). Effects of oral contraceptives on affective fluctuations associated with the menstrual cycle. Psychosomatic Medicine, 33, 515-537.
52. Parlee, M. B. (1973). The premenstrual syndrome. Psychological Bulletin, 80, 454-465.
53. Parlee, M. B. (1974). Stereotypical beliefs about menstruation: A methodological note on the Moos MDQ and some new data. Psychosomatic Medicine, 36, 229-240.
54. Patwardhan, R. V., Desmond, P. V., Johnson, R. F., & Schenker, S. (1980). Impaired elimination of caffeine by oral contraceptive steroid. Journal of Laboratory & Clinical Medicine, 95, 603-608.
55. Rapkin, A. J., Morgan, M., Goldman, L., Brann, D. W., Simone, D., & Mahesh, V. B. (1997). Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstetrics & Gynecology, 90, 709-714.
56. Roca, C. A., Schmidt, P. J., Altemus, M., Deuster, P., Sanaceau, M. A., Putnam, K, & Rubinow, D. R. (2003). Differential menstrual cycle regulation of hypothalamic-pituitaryadrenal axis in women with premenstrual syndrome and controls. Journal of Clinical Endocrinology & Metabolism, 88, 3057-3063.
57. Roca, C. A., Schmidt, P. J., & Rubinow, D. R. (1999). A follow-up study of premenstrual syndrome. Journal of Clinical Psychiatry, 60, 763-766.
58. Rossignol, A. M. (1985). Caffeine-containing beverages and premenstrual syndrome in young women. American Journal of Public Health, 75, 1335-1337.
59. Rossignol, A. M., & Bonnlander, H. (1990). Caffeine-containing beverages, total fluid consumption, and premenstrual syndrome. American Journal of Public Health, 80, 1106-1109.
60. Rossignol, A. M., Bonnlander, H., Song, L., & Phillis, J. W. (1991). Do women with premenstrual symptoms self-medicate with caffeine? Epidemiology, 2, 403-408.
61. Rossignol, A. M., Zhang, J., Chen, Y., & Xiang, Z. (1989). Tea and premenstrual syndrome in the People's Republic of China. American Journal of Public Health, 79, 67-69.
62. Rubinow, D. R., Hoban, M. C., & Grover, G. N. (1988). Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. American Journal of Obstetrics & Gynecology, 158, 11-15.
63. Rubinow, D. R., & Roy-Byrne, P. (1984). Premenstrual syndromes: Overview from a methodologic prespective. American Journal of Psychiatry, 141, 163-172.
64. Ruble, D. N. (1977). Menstrual syndrome: A reinterpretation. Science, 197, 291-292.
65. Sawetawan, C., Carr, B. R., McGee, E., Bird, I. M., Hong, T. L., & Rainery, W. E. (1996). Inhibin and activin differentially regulate androgen production and 17-a-hydroxylase expression in human ovarian thecal-like tumor cells. Journal of Endocrinology, 148, 213-221.
66. Schmidt, P. J., Grover, G. N., & Rubinow, D. R. (1993). Alprazolam in the treatment of premenstrual syndrome, a double-blind, placebo-controlled trail. Archives of General Psychiatry, 50, 467-473.
67. Schmidt, P. J., Nieman, L., Danaceau, M. A., Tobin, M. B., Roca, C. A., Murphy, J. H., & Rubinow, D. R. (2000). Estrogen replacement in perimenopause-related depression: A preliminary report. American Journal of Obstetrics and Gynecology, 183, 414-420.
68. Schuckit, M., Daly, V., Herrman, G., & Hineman, S. (1975). Premenstrual symptoms and depression in a university population. Diseases of the Nervous System, 36, 516-517.
69. Severino, S., & Moline, M. L. (1988). Premenstrual syndrome: A clinician's guide. New York: The Guilford Press.
70. Silberg, J. L., Martin, N. G., & Heath, A. C. (1987). Genetic and environmental factors in primary dysmonorrhea and its relationship to anxiety, depression, and neuroticism. Behavior Genetics, 17, 363-83.
71. Silberstein, S. D. & Merriam, G. R. (2000). Physiology of the menstrual cycle. Cephalalgia, International Journal of Headache, 20, 148-154.
72. Silva, C. M., Cigante, D. P., Carret, M. L., & Fassa, A. G. (2006). Population study of premenstrual syndrome. Revista de Saude Publica, 40, 47-56.
73. Slade, P., & Jenner, F. A. (1980). Attitudes to female roles, aspects of menstruation and complaining of menstrual symptoms. British Journal of Social and Clinical Psychology, 19, 109-113.
74. Steiner, M., Haskett, R. F., & Carroll, B. J. (1980). Premenstrual tension syndrome: The development of research diagnostic criteria and new rating scales. Acta Psychiatrica Scandinavica, 62, 177-190.
75. Subhash, C. B., & Shashi, K. B. (2002). Diagnosis and treatment of premenstrual dysphoric disorder. American Family Physician, 66, 1239-1248.
76. Sullivan, M. G. (2003). Severe menopausal symptoms linked to severe PMS. Clinical Psychiatry News, 31, 52-53.
77. Tsafriri A. L. (1994). Nonsteroidal regulators of ovarian function. In E. Knobil & J. D. Neill (Eds.), The physiology of reproduction, 2nd ed., vol. 1 (pp. 817-860). New York: Raven Press.
78. Vo, H. T., Rubinow, D. R., & Smith, B. D. (in preparation). The effect of caffeine on premenstrual syndrome.
79. Walker, A., (1995). Theory and methodology in premenstrual syndrome research. Social Science and Medicine, 41, 793-800.
80. Walker, A. (1997). The menstrual cycle. London: Routledge.
81. Wetzel, R., Reich, T., McClure, J., & Wald, J. (1975). Premenstrual affective syndrome and affective disorder. British Journal of Psychiatry, 127, 219-221.
82. WHO. (1992). The ICD-10 classification of mental and behavioral disorders: Clinical descriptions and diagnostic guidelines. Geneva, Switzerland: WHO.
83. Wyatt, K. M, Dimmock, P. W., & O'Brien, P. M. (2000). Premenstrual syndrome. In S. Barton (Ed.), Clinical evidence, 4th issue (pp. 1121-1133). London: BMJ Publishing Group.
84. Wyatt, K. M. Dimmock, P. W., Jones, P. M., Obhrai, M., & O'Brien, P. M. (2001). Efficacy of progesterone and progestogens in management of premenstrual syndrome: Systemic review. British Medical Journal, 323, 776-780.
85. Zeiner, A. R., & Kegg, P. S. (1981). Effects of sex steroids on ethanol pharmacokinetics and autonomic reactivity. Progress in Biochemical & Pharmacology, 18, 130-142.